Dr. Miele Cosmed Group S.A. (WSE: DMG)
Poland
· Delayed Price · Currency is PLN 5.40
-0.06 (-1.10%)
Jan 20, 2025, 9:00 AM CET
Dr. Miele Cosmed Group Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 483.07 | 444.48 | 396.57 | 351.87 | 364.81 | 309.86 | Upgrade
|
| Revenue Growth (YoY) | 11.62% | 12.08% | 12.70% | -3.55% | 17.73% | 3.01% | Upgrade
|
| Cost of Revenue | 276.01 | 272.98 | 271.8 | 218.41 | 203.5 | 183.95 | Upgrade
|
| Gross Profit | 207.06 | 171.5 | 124.77 | 133.46 | 161.31 | 125.91 | Upgrade
|
| Selling, General & Admin | 123.06 | 105.06 | 94.46 | 94.93 | 84.98 | 76.24 | Upgrade
|
| Other Operating Expenses | 22.02 | 21.59 | 17.81 | 12.71 | 34.09 | 30.09 | Upgrade
|
| Operating Expenses | 157.22 | 138.61 | 123.6 | 118.28 | 129.99 | 117.14 | Upgrade
|
| Operating Income | 49.84 | 32.89 | 1.17 | 15.17 | 31.33 | 8.77 | Upgrade
|
| Interest Expense | -5.1 | -4.69 | -3.72 | -1.37 | -2.41 | -3.08 | Upgrade
|
| Interest & Investment Income | - | 0.12 | 0.18 | 0.12 | 0.18 | 0.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.24 | -1.24 | 0.21 | -0.33 | 1.85 | -0.19 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.08 | -0.21 | -0.26 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 43.46 | 27.04 | -2.24 | 13.38 | 30.69 | 5.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.16 | 0.16 | 0.37 | -0.12 | 0.62 | 1.38 | Upgrade
|
| Asset Writedown | - | - | -0.23 | - | - | -1.55 | Upgrade
|
| Pretax Income | 43.62 | 27.2 | -2.1 | 13.26 | 31.3 | 4.93 | Upgrade
|
| Income Tax Expense | 7.67 | 4.98 | 0.17 | 1.66 | 2.68 | 1.58 | Upgrade
|
| Earnings From Continuing Operations | 35.95 | 22.22 | -2.27 | 11.6 | 28.63 | 3.35 | Upgrade
|
| Net Income to Company | 35.95 | 22.22 | -2.27 | 11.6 | 28.63 | 3.35 | Upgrade
|
| Net Income | 35.95 | 22.22 | -2.27 | 11.6 | 28.63 | 3.35 | Upgrade
|
| Net Income to Common | 35.95 | 22.22 | -2.27 | 11.6 | 28.63 | 3.35 | Upgrade
|
| Net Income Growth | 238.11% | - | - | -59.49% | 755.78% | - | Upgrade
|
| Shares Outstanding (Basic) | 87 | 87 | 87 | 87 | 87 | 87 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 87 | 87 | 87 | 87 | 87 | Upgrade
|
| EPS (Basic) | 0.41 | 0.25 | -0.03 | 0.13 | 0.33 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.40 | 0.25 | -0.03 | 0.13 | 0.33 | 0.04 | Upgrade
|
| EPS Growth | 233.34% | - | - | -60.34% | 755.79% | - | Upgrade
|
| Free Cash Flow | 15.93 | 21.56 | -0.75 | 8.36 | 17.42 | 11.15 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.25 | -0.01 | 0.10 | 0.20 | 0.13 | Upgrade
|
| Dividend Per Share | 0.090 | 0.090 | - | 0.030 | 0.060 | - | Upgrade
|
| Dividend Growth | - | - | - | -50.00% | - | - | Upgrade
|
| Gross Margin | 42.86% | 38.58% | 31.46% | 37.93% | 44.22% | 40.63% | Upgrade
|
| Operating Margin | 10.32% | 7.40% | 0.30% | 4.31% | 8.59% | 2.83% | Upgrade
|
| Profit Margin | 7.44% | 5.00% | -0.57% | 3.30% | 7.85% | 1.08% | Upgrade
|
| Free Cash Flow Margin | 3.30% | 4.85% | -0.19% | 2.38% | 4.78% | 3.60% | Upgrade
|
| EBITDA | 59.6 | 42.47 | 10.69 | 24.29 | 40.53 | 17.98 | Upgrade
|
| EBITDA Margin | 12.34% | 9.55% | 2.70% | 6.90% | 11.11% | 5.80% | Upgrade
|
| D&A For EBITDA | 9.76 | 9.58 | 9.52 | 9.12 | 9.2 | 9.21 | Upgrade
|
| EBIT | 49.84 | 32.89 | 1.17 | 15.17 | 31.33 | 8.77 | Upgrade
|
| EBIT Margin | 10.32% | 7.40% | 0.29% | 4.31% | 8.59% | 2.83% | Upgrade
|
| Effective Tax Rate | 17.59% | 18.31% | - | 12.52% | 8.55% | 32.14% | Upgrade
|
| Revenue as Reported | 38.59 | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.